Onesource Specialty Pharma

Onesource Specialty Pharma Net Debt per Share

The Net Debt per Share of Onesource Specialty Pharma (ONESOURCE.NS) as of Oct 22, 2026 is 122.22 INR. In the previous year, Net Debt per Share was 81.91 INR — a change of 49.22% (higher).

Net Debt per Share

122.22INR

YoY

49.22%

Last updated:

Net Debt per Share of Onesource Specialty Pharma is 2026 122.22 INR. Net Debt per Share of Onesource Specialty Pharma was 2025 81.91 INR. It decreases by 49.22% higher compared to the previous year.

The Onesource Specialty Pharma Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2023
29.22 INR
Jan 1, 2024
23.69 INR
Jan 1, 2025
81.91 INR
Jan 1, 2026
122.22 INR
The Onesource Specialty Pharma Net Debt per Share history
YEARNet Debt per ShareYoY
122.22INR+49.22%
81.91INR+245.67%
23.69INR-18.90%
29.22INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Net Debt per Share of Onesource Specialty Pharma is 122.22 INR in 2026.

Net Debt per Share of Onesource Specialty Pharma changed from 81.91 INR to 122.22 INR, representing a 49.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Onesource Specialty Pharma

All Key Metrics — Onesource Specialty Pharma